For women diagnosed with hormone-receptor-positive DCIS, a new study has determined that low dose Tamoxifen after surgery reduced the risk of the disease coming back. Low dose tamoxifen also reduced the risk of developing a new invasive breast cancer.
Read more on Low Dose Tamoxifen Reduces Risk Of Recurrence For Some Breast Cancers…
Read More ADH, ALH breast cancers, DCIS, LCIS, reduce breast cancer recurrence
According to the American Cancer Society, pancreatic cancer is currently the third leading cause of cancer-related deaths in the U.S., and rates are rising faster than any other cancer in the country. Researchers predict it will become the second deadliest cancer in the U.S. by 2030, second only to lung cancer.
Read more on New Research Links BRCA2 Breast Cancer Gene With Pancreatic Cancer Risk…
Read More BRCA gene, pancreatic cancer treatment, PARP-I
Hello, Margulies office people!
This is just a quick note to thank you all for all the concern, assistance, and care you have given me over the past month. One month ago today I had the biopsy that came back with a Grade 1 cancer result, and today I’m at work with only a couple of scars and a cute little purple binder covering my cancer-free chest. 🙂 I know there is more treatment ahead of me, but I am very grateful to be so quickly and easily to this point. I can only pray that the rest of the process will be as efficient, straightforward, and reassuring as my experience with your office has been.
Read more on A Special Note Of Gratitude From A Relieved Patient…
Read More Breast cancer surgery, breast cancer treatment Knoxville
Some women who undergo In Vitro Fertilization (IVF) worry that the process may increase their risk of developing breast cancer. It’s estimated that over 8 million babies have been born worldwide as a result of IVF and other advanced fertility treatments since the first IVF birth in 1978. In the U.S., 1.5% of all births are the result of using artificial reproductive therapies, which is the highest percentage to date.
Read more on Does Fertility Treatment Affect Your Risk of Breast Cancer?…
Read More DCIS, IVF and breast cancer
I’m excited to share news about a significant advancement in treatment for patients with HER2-positive early breast cancer. A phase III trial shows that a treatment called Kadcyla® (TDM-1) lowered the risk of recurrence of invasive breast cancer or death by 50% compared to Herceptin® in patients with HER2-positive early breast cancer with residual disease after pre-surgical (neoadjuvant = NST) therapy.
Read more on Encouraging News For Treatment Of HER2-positive Early Breast Cancer…
Read More clinical trials for HER2-positive breast cancer, KadcylaYou’ve most likely seen the ads on TV for home-kits like 23andMe that can tell you about your ancestry through saliva testing. 23andMe is now offering the ability to give you FDA approved health reports as well, and people are curious if these reports can determine if they carry the BRCA1 and BRCA2 genes, which increase the risk of breast and ovarian cancer.
Read more on Concerns About Genetic Testing Kits For Detecting Breast Cancer Genes…
Read More Breast Cancer Genes, Detecting Breast Cancer Genes, Genetic testing, Genetic Testing Kits
Dr. Aaron Margulies & Imeda Margulies, Director of Clinical Genetic Services
My journey as a Breast Surgical Oncologist began in California where I first practiced general surgery in a suburb of San Francisco. General surgery is rewarding, but what I found most fulfilling was counseling and treating patients with breast cancer.
Read more on What Differentiates Me From My Peers?…
Read More breast surgical oncologist, Hidden Scar surgery, Oncoplastic Breast Surgeon
Breast cancer surgical techniques are constantly evolving, and I’m passionate about keeping up with the latest advances. As I’ve said before, by the time a physician retires 80% of their practice was learned after residency.
Read more on Honing My Surgical Techniques For Better Cosmetic Outcomes…
Read More Breast Reconstruction, oncoplastic surgery
Breaking news in breast cancer research will affect whether or not a significant number of women with early-stage breast cancer can forgo chemotherapy. On June 3rd, at ASCO (the American Society of Clinical Oncology annual meeting) researchers presented their findings of a highly-anticipated study called the TAILORx trial, which followed almost 10,000 women with early-stage breast cancer.
Read more on Breakthrough Study Reveals Fewer Early-Stage Breast Cancer Patients Need Chemo…
Read More Breast Cancer Treatment, Chemotherapy, endocrine therapy
According to the American Cancer Society, an estimated 266,120 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S. in 2018, along with 63,960 new cases of non-invasive (DCIS) breast cancer. Approximately 1 in 8 U.S. women will develop invasive breast cancer over the course of her lifetime.
Read more on TN Breast and Cervical Cancer Program Serves Lower Income Women…
Read More breast cancer insurance, Tennessee breast cancer services